Date: 2015-05-19
Type of information: Construction of new premises
Compound: biologics manufacturing facility in Cruiserath (Ireland)
Company: Jacobs Engineering Group (USA - CA) BMS (USA - NY)
Therapeutic area: Technology - Services
Type agreement: construction of new premises services contract
Action mechanism:
Disease:
Details: * On May 19, 2015, Jacobs Engineering Group announced that it received a contract from BMS to provide construction management services for a new large-scale biologics manufacturing facility in Cruiserath, County Dublin, Ireland. Jacobs is also providing architectural and engineering services for the facility, which is being built to produce multiple therapies for the company’s robust and growing portfolio of approved and investigational biologic medicines, and to increase BMS' biologics manufacturing capacity. The new facility is expected to include multiple large scale bioreactors, a purification area, as well as office and laboratory space. BMS' Board of Directors has approved initial funding that will support the first phase of the project, with the full cost of the facility expected to be finalized in the second half of 2015. The facility is estimated to be operational in 2019.
Financial terms:
Latest news:
